ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04217	Necroptosis	15/54	178/7206	1.61029197355e-12
ko04621	NOD-like receptor signaling pathway	14/54	157/7206	4.64169772561e-12
ko05152	Tuberculosis	13/54	187/7206	6.97140503943e-10
ko04064	NF-kappa B signaling pathway	10/54	96/7206	1.61397908201e-09
ko05168	Herpes simplex infection	12/54	182/7206	6.37809387285e-09
ko04620	Toll-like receptor signaling pathway	9/54	100/7206	4.20715599116e-08
ko05164	Influenza A	10/54	167/7206	3.38979270402e-07
ko05161	Hepatitis B	10/54	173/7206	4.70956853914e-07
ko04668	TNF signaling pathway	8/54	120/7206	2.56698334765e-06
ko05162	Measles	8/54	120/7206	2.56698334765e-06
ko05321	Inflammatory bowel disease (IBD)	6/54	56/7206	3.24468740099e-06
ko05145	Toxoplasmosis	8/54	126/7206	3.70716085712e-06
ko04210	Apoptosis	9/54	180/7206	6.2578051613e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	9/54	191/7206	1.0143061623e-05
ko05140	Leishmaniasis	6/54	75/7206	1.80470667985e-05
ko05144	Malaria	5/54	45/7206	1.90385789235e-05
ko05142	Chagas disease (American trypanosomiasis)	7/54	130/7206	4.62739546161e-05
ko04380	Osteoclast differentiation	7/54	134/7206	5.61888344024e-05
ko04622	RIG-I-like receptor signaling pathway	5/54	62/7206	9.15667283476e-05
ko05134	Legionellosis	5/54	74/7206	0.000212955740844
ko04060	Cytokine-cytokine receptor interaction	7/54	191/7206	0.000507851530888
ko05320	Autoimmune thyroid disease	3/54	29/7206	0.00126650258773
ko05340	Primary immunodeficiency	3/54	30/7206	0.00139980138579
ko01524	Platinum drug resistance	4/54	76/7206	0.00242480224351
ko04612	Antigen processing and presentation	4/54	77/7206	0.00254359722028
ko04672	Intestinal immune network for IgA production	3/54	37/7206	0.00258165575259
ko05323	Rheumatoid arthritis	4/54	89/7206	0.00429555487954
ko05203	Viral carcinogenesis	7/54	277/7206	0.00432723947844
ko04215	Apoptosis - multiple species	3/54	47/7206	0.00511092298958
ko05160	Hepatitis C	5/54	153/7206	0.00553333538129
ko04624	Toll and Imd signaling pathway	3/54	49/7206	0.00574638628823
ko04650	Natural killer cell mediated cytotoxicity	4/54	97/7206	0.00583316888875
ko05146	Amoebiasis	4/54	99/7206	0.00626813606891
ko05310	Asthma	2/54	17/7206	0.00697537435219
ko04145	Phagosome	5/54	162/7206	0.00702597466271
ko05416	Viral myocarditis	3/54	55/7206	0.00792853005827
ko04659	Th17 cell differentiation	4/54	106/7206	0.00795968861696
ko05200	Pathways in cancer	9/54	492/7206	0.0100978313635
ko05330	Allograft rejection	2/54	24/7206	0.0136901300292
ko04214	Apoptosis - fly	3/54	72/7206	0.016487723196
ko04630	Jak-STAT signaling pathway	4/54	132/7206	0.0167893729966
ko05169	Epstein-Barr virus infection	5/54	206/7206	0.0184916617709
ko04940	Type I diabetes mellitus	2/54	32/7206	0.0236831615387
ko04670	Leukocyte transendothelial migration	4/54	151/7206	0.0260695055471
ko04657	IL-17 signaling pathway	3/54	87/7206	0.0270975872209
ko05133	Pertussis	3/54	87/7206	0.0270975872209
ko04722	Neurotrophin signaling pathway	4/54	160/7206	0.0313624767025
ko04071	Sphingolipid signaling pathway	4/54	162/7206	0.0326189869565
ko04932	Non-alcoholic fatty liver disease (NAFLD)	4/54	182/7206	0.0468109837696
ko04141	Protein processing in endoplasmic reticulum	4/54	184/7206	0.048393534304